MIDAZOLAM
Healthy Controls
University of Texas Southwestern Medical CenterSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
0 Active assets in the Healthy Controls cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM Children's Hospital Los Angeles | D |
Same molecule, other indications
MIDAZOLAM is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →